Morganella morganii is a Gram-negative, facultatively anaerobic bacterium belonging to the family Enterobacteriaceae, commonly found in the human intestinal tract. Although often considered an opportunistic pathogen, it can cause urinary tract infections, wound infections, sepsis, and other nosocomial infections, particularly in immunocompromised patients. Correct identification of Morganella morganii in clinical microbiology laboratories is crucial for proper diagnosis and treatment. Biochemical tests play a central role in distinguishing this bacterium from other members of Enterobacteriaceae, helping microbiologists determine its metabolic characteristics, enzyme activities, and fermentation patterns. Understanding these biochemical traits is essential not only for accurate identification but also for epidemiological studies and antimicrobial susceptibility assessments.
Overview of Morganella morganii
Morganella morganii was first described in 1906 and has since been recognized as a clinically significant pathogen, especially in hospital settings. It is non-lactose fermenting, motile, and urease-positive, exhibiting growth on standard bacteriological media. The bacterium’s opportunistic nature means it primarily affects patients with underlying health conditions, but it is also occasionally isolated from healthy individuals. Its identification relies heavily on biochemical testing, which can differentiate it from similar Gram-negative bacteria such as Proteus and Providencia species.
General Characteristics
- Gram-negative rod-shaped bacterium
- Motile with peritrichous flagella
- Facultatively anaerobic
- Non-lactose fermenting
- Urease-positive
Importance of Biochemical Tests
Biochemical tests are laboratory procedures used to assess the metabolic and enzymatic capabilities of bacteria. For Morganella morganii, these tests help identify specific traits such as sugar fermentation patterns, enzyme production, and resistance to certain compounds. Accurate biochemical profiling allows microbiologists to differentiate M. morganii from other Enterobacteriaceae species, guiding appropriate treatment and infection control measures. In clinical practice, a combination of tests is typically used to confirm identification, as reliance on a single test may lead to misidentification due to overlapping characteristics with related bacteria.
Purpose of Biochemical Testing
- Identification of bacterial species in clinical specimens
- Differentiation from closely related Enterobacteriaceae
- Determination of metabolic and enzymatic properties
- Guiding antibiotic selection and infection control strategies
Common Biochemical Tests for Morganella morganii
Morganella morganii exhibits distinctive results in various biochemical tests. These results are widely used in microbiology laboratories to confirm its presence in clinical or environmental samples. The combination of positive and negative reactions in specific tests forms a characteristic profile that is unique to the species.
Urease Test
The urease test is one of the hallmark tests for M. morganii. The bacterium produces urease, an enzyme that hydrolyzes urea into ammonia and carbon dioxide, leading to an alkaline reaction. In the laboratory, a positive urease test is indicated by a color change in the urea broth or agar from yellow/orange to pink, confirming the presence of urease activity.
Indole Test
Morganella morganii is indole-positive, meaning it can metabolize tryptophan to produce indole. In practice, Kovac’s reagent is added to a culture grown in tryptophan-rich media, and a red or pink layer forms at the top of the broth, indicating a positive reaction. This test is significant for differentiating M. morganii from other urease-positive bacteria like Providencia rettgeri, which may also produce similar traits.
Triple Sugar Iron (TSI) Test
The TSI test assesses carbohydrate fermentation and hydrogen sulfide production. Morganella morganii typically produces an alkaline slant (red) and acid butt (yellow), indicating glucose fermentation only, with no gas or hydrogen sulfide production. This reaction pattern helps differentiate it from Proteus species, which can produce hydrogen sulfide and gas in the medium.
Motility Test
Morganella morganii is motile, which can be observed using semi-solid agar or hanging drop preparations. Motility is characterized by diffuse growth radiating outward from the stab line in motility agar. This feature distinguishes it from non-motile Enterobacteriaceae species such as Klebsiella.
Lactose Fermentation
M. morganii is a non-lactose fermenter, meaning it does not ferment lactose to produce acid. On MacConkey agar, colonies typically appear pale or colorless, contrasting with pink lactose-fermenting Enterobacteriaceae such as Escherichia coli. This property is critical for preliminary differentiation in mixed cultures.
Citrate Utilization Test
The citrate test determines if the bacterium can use citrate as the sole carbon source. M. morganii can utilize citrate, resulting in a positive reaction indicated by a color change from green to blue in Simmons’ citrate agar. This test helps in the differentiation from other non-citrate utilizing species.
Additional Biochemical Reactions
Other biochemical tests that provide further confirmation include the following
- Ornithine decarboxylase positive reaction
- Lysine decarboxylase negative reaction
- Phenylalanine deaminase positive reaction
- Gelatin hydrolysis positive reaction
These additional tests help create a comprehensive biochemical profile that is highly specific for M. morganii.
Clinical Significance of Biochemical Identification
Accurate identification of Morganella morganii using biochemical tests is critical in clinical settings. Misidentification can lead to inappropriate antimicrobial therapy and worsen patient outcomes. Biochemical testing not only confirms the presence of the bacterium but also provides insights into its metabolic capabilities, which can influence virulence and resistance patterns. Infections caused by M. morganii may require targeted antibiotics, as the species is known to harbor resistance mechanisms, including beta-lactamase production.
Applications in Clinical Microbiology
- Accurate diagnosis of urinary tract infections and sepsis
- Differentiation from other Enterobacteriaceae in mixed cultures
- Guidance for appropriate antibiotic therapy
- Monitoring epidemiological trends and resistance patterns
Morganella morganii biochemical tests are essential tools in the identification and differentiation of this opportunistic pathogen from other Enterobacteriaceae species. Key tests such as urease, indole, TSI, citrate utilization, and motility provide a reliable profile that can be used in clinical laboratories for accurate diagnosis. Understanding the biochemical characteristics of M. morganii is crucial for guiding treatment decisions, managing infections, and conducting epidemiological studies. By combining multiple tests, microbiologists can confidently identify this bacterium and ensure effective patient care, highlighting the importance of biochemical testing in modern microbiology.